CAMBRIDGE, United Kingdom, Aug. 04, 2025 (GLOBE NEWSWIRE) — Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that patient…Read More
You might also be interested in reading DeFi lending protocol created by ex-QuadrigaCX co-founder surpassed $50M in TVL.
